Literature DB >> 27453588

Functionalized ferrocenes: The role of the para substituent on the phenoxy pendant group.

José L Vera1, Jorge Rullán1, Natasha Santos1, Jesús Jiménez1, Joshua Rivera1, Alberto Santana1, Jon Briggs2, Arnold L Rheingold2, Jaime Matta3, Enrique Meléndez1.   

Abstract

Six ferrocenecarboxylates with phenyl, 4-(1H-pyrrol-1-yl)phenyl, 4-fluorophenyl, 4-chlorophenyl, 4-bromophenyl, 4-iodophenyl as pendant groups were synthesized and fully characterized by spectroscopic, electrochemical and X-ray diffraction methods. The anti-proliferative activity of these complexes were investigated in hormone dependent MCF-7 breast cancer and MCF-10A normal breast cell lines, to determine the role of the para substituent on the phenoxy pendant group. The 4-fluorophenyl ferrocenecarboxylate is inactive in both cell lines while 4-(1H-pyrrol-1-yl)phenyl ferrocenecarboxylate is highly cytotoxic in both cell lines. 4-chlorophenyl and 4-bromophenyl ferrocenecarboxylates have moderate to good anti-proliferative activity in MCF-7 and low anti-proliferative activity on normal breast cell line, MCF-10A whereas the 4-iodophenyl analog is highly toxic on normal breast cell line. The phenyl ferrocenecarboxylate has proliferative effects on MCF-7 and is inactive in MCF-10A. Docking studies between the complexes and the alpha-estrogen receptor (ERα) were performed to search for key interactions which may explain the anti-proliferative activity of 4-bromophenyl ferrocenecarboxylate. Docking studies suggest the anti-proliferative activity of these ferrocenecarboxylates is attributed to the cytotoxic effects of the ferrocene group and not to anti-estrogenic effects.

Entities:  

Keywords:  Anti-cancer; Docking; Estrogen receptor; Ferrocenecarboxylate; MCF-10A; MCF-7

Year:  2014        PMID: 27453588      PMCID: PMC4957819          DOI: 10.1016/j.jorganchem.2013.10.002

Source DB:  PubMed          Journal:  J Organomet Chem        ISSN: 0022-328X            Impact factor:   2.369


  23 in total

1.  Recent applications of chiral ferrocene ligands in asymmetric catalysis.

Authors:  Ramón Gómez Arrayás; Javier Adrio; Juan Carlos Carretero
Journal:  Angew Chem Int Ed Engl       Date:  2006-11-27       Impact factor: 15.336

2.  Water stability and cytotoxic activity relationship of a series of ferrocenium derivatives. ESR insights on the radical production during the degradation process.

Authors:  Giovanni Tabbì; Claudio Cassino; Giorgio Cavigiolio; Donato Colangelo; Annalisa Ghiglia; Ilario Viano; Domenico Osella
Journal:  J Med Chem       Date:  2002-12-19       Impact factor: 7.446

3.  Preparation of new polycyclic compounds derived from benzofurans and furochromones. An approach to novel 1,2,3-thia-, and selena-diazolofurochromones of anticipated antitumor activities.

Authors:  Sanaa M Sh Atta; Dalia S Farrag; Ayman M K Sweed; A H Abdel-Rahman
Journal:  Eur J Med Chem       Date:  2010-08-06       Impact factor: 6.514

4.  Vectorized ferrocenes with estrogens and vitamin D2: synthesis, cytotoxic activity and docking studies.

Authors:  José Vera; Li Ming Gao; Alberto Santana; Jaime Matta; Enrique Meléndez
Journal:  Dalton Trans       Date:  2011-08-18       Impact factor: 4.390

Review 5.  Metal complex SERMs (selective oestrogen receptor modulators). The influence of different metal units on breast cancer cell antiproliferative effects.

Authors:  Anne Vessières; Siden Top; Wolfgang Beck; Elizabeth Hillard; Gérard Jaouen
Journal:  Dalton Trans       Date:  2005-09-27       Impact factor: 4.390

6.  Halogen bonding--a novel interaction for rational drug design?

Authors:  Yunxiang Lu; Ting Shi; Yong Wang; Huaiyu Yang; Xiuhua Yan; Xiaoming Luo; Hualiang Jiang; Weiliang Zhu
Journal:  J Med Chem       Date:  2009-05-14       Impact factor: 7.446

7.  Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability.

Authors:  F Denizot; R Lang
Journal:  J Immunol Methods       Date:  1986-05-22       Impact factor: 2.303

8.  Ferricenium complexes: a new type of water-soluble antitumor agent.

Authors:  P Köpf-Maier; H Köpf; E W Neuse
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

9.  Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines.

Authors:  Siden Top; Anne Vessières; Guy Leclercq; Jacques Quivy; J Tang; J Vaissermann; Michel Huché; Gérard Jaouen
Journal:  Chemistry       Date:  2003-11-07       Impact factor: 5.236

10.  Synthesis, structure, electrochemistry, and cytotoxic properties of ferrocenyl ester derivatives.

Authors:  Li Ming Gao; Ramón Hernández; Jaime Matta; Enrique Meléndez
Journal:  Met Based Drugs       Date:  2009-03-24
View more
  3 in total

1.  Para-Substituted Functionalised Ferrocene Esters with Novel Antibacterial Properties.

Authors:  Kevin Muñoz Forti; Faviola Bernard; Gustavo Santiago-Collazo; Waldemar Garcia; Jose L Vera; Enrique Meléndez; Edu B Suarez-Martinez
Journal:  J Clin Diagn Res       Date:  2018-02

2.  Crystal structure of 16-ferrocenylmethyl-3β-hydroxy-estra-1,3,5(10)-trien-17-one: a potential chemotherapeutic drug.

Authors:  José A Carmona-Negrón; Mariola M Flores-Rivera; Zaibeth Díaz-Reyes; Curtis E Moore; Arnold L Rheigold; Enrique Meléndez
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2016-05-27

Review 3.  Ferrocene-Based Compounds with Antimalaria/Anticancer Activity.

Authors:  Sijongesonke Peter; Blessing Atim Aderibigbe
Journal:  Molecules       Date:  2019-10-07       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.